Enfermería
DEPARTMENT
General University Hospital of Patras
Patrás, GreciaPublications in collaboration with researchers from General University Hospital of Patras (9)
2023
-
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry
American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87
2020
-
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries
American Heart Journal, Vol. 220, pp. 108-115
-
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor
International Journal of Cardiology, Vol. 301, pp. 200-206
-
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries
American Journal of Cardiovascular Drugs, Vol. 20, Núm. 3, pp. 259-269
-
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
European Journal of Preventive Cardiology, Vol. 27, Núm. 7, pp. 696-705
2019
-
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry (American Journal of Cardiovascular Drugs, (2019), 19, 4, (381-391), 10.1007/s40256-019-00339-3)
American Journal of Cardiovascular Drugs
-
Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
American Journal of Cardiovascular Drugs, Vol. 19, Núm. 4, pp. 381-391
2018
-
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry
Thrombosis Research, Vol. 167, pp. 142-148
-
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry
International Journal of Cardiology, Vol. 273, pp. 29-33